We have discovered that certain dihydropyran sub-
strates serve as nonsymmetric bis-electrophiles for Pd-
AA cascades with cyclic β-dicarbonyl compounds. This
methodology provides rapid access to unsaturated furo-
[3,2-c]pyran ring systems with excellent regio- and diaste-
reoselectivity. The Pd-AA cascade was investigated using
cis-1, which was prepared in four steps from furfuryl
alcohol via known alcohol 25 (Scheme 1).
Table 1. Optimization of the Pd-AA Cascade with cis-1
entry
catalyst (mol %)
solvent
equiv 3 yielda
1
Pd2(dba)3/PPh3 (10)b CH2Cl2
Pd2(dba)3/PPh3 (10)b CH3CN
Pd2(dba)3/PPh3 (10)b THF
Pd2(dba)3/PPh3 (10)b CH2Cl2
Pd2(dba)3/PPh3 (10)b CH3CN/NEt3
Pd2(dba)3/PPh3 (10)b CH3CN/NEt3
Pd2(dba)3/PPh3 (10)b toluene
1.0
1.0
1.0
2.2
2.2
1.0
1.0
1.0
1.0
1.0
1.0
30%
12%
44%
5%c
Scheme 1. Synthesis of Pyran Substrates, cis-1 and trans-1
2
3
4
d
d
5
42%
40%
65%
71%
83%
71%
56%e
6
7
8
Pd(PPh3)4 (10)
Pd(PPh3)4 (5)
Pd(PPh3)4 (5)
Pd(PPh3)4 (1)
toluene
9
toluene
toluene/NEt3
toluene
d
10
11
a Isolated yield. b 2:1 ratio of P/Pd was used. c 39% recovered cis-1
and 4% O-alkylation product cis-5 were also isolated. d 1.0 equiv of NEt3
was added. e 9% O-alkylation product cis-5 was also isolated.
Initial solvent screening experiments employed 4-hydroxy-
6-methyl-R-pyrone (3) as the β-dicarbonyl compound and
provided modest yields of furopyran 4 (Table 1, entries
1À3). Interestingly, the use of excess 3 was detrimental
to the reaction (entry 4), leaving unreacted cis-1 and
producing the undesired O-alkylation side product, cis-5
(Scheme 2). The negative effects of excess 4-hydroxy-R-
pyrone could be countered by adding triethylamine to the
reaction mixture (entry 5). Toluene was found to be the
optimal reaction solvent, and when used in conjunction
with 5 mol % of Pd(PPh3)4, the desired product 4 was
obtained in 83% yield (entry 9).
Scheme 2. Conversion of cis-5 into 4 and ORTEP Drawing of 4
with Thermal Ellipsoids at 50% Probability
Pd-AA with soft nucleophiles typically proceeds through
a double inversion of configuration;6 however, the Pd-AA
cascade of trans-1 with 3 also produced the cis-fused
furopyran, 4 (Table 2). The cis-stereochemistry of 4 was
confirmed by X-ray crystallographic analysis (Scheme 2).7
This is presumably a consequence of the prohibitively
large amount of strain energy present in the trans-fused
furopyran product, 6,8 since the relative energy difference
between the cis- and trans-fused products was calculated to
be 51 kJ/mol.9 While an inner-sphere process could be
invoked to explain the overall retention of configuration,
the higher catalyst loading required for efficient transfor-
mation of trans-1 into 4 (Table 2, entry 3) suggests that the
initial syn-palladium complex, 7, is isomerized by intermolec-
ular nucleophilic attack of a transient Pd(0) species (step VI,
Scheme 3).10 To validate this hypothesis we investigated
the Pd-AA cascade of cyclohexene-based substrate trans-
811(Scheme 4). This substrate provides an opportunity to
evaluate the putative π-allyl-Pd isomerization without the
possibility of the reaction proceeding through an oxonium
intermediate, as may be the case for trans-1. Ultimately,
(4) Agelastatin A: Trost, B. M.; Dong, G. Chem.;Eur. J 2009, 15,
6910. Huperzine A: Campiani, G.; Sun, L.-Q.; Kozikowski, A. P.;
Aagaard, P.; McKinney, M. J. Org. Chem. 1993, 58, 7660. Kaneko, S.;
Yoshino, T.; Katoh, T.; Terashima, S. Tetrahedron 1998, 54, 5471. He,
X.-C.; Wang, B.; Yu, G.; Bai, D. Tetrahedron: Asymmetry 2001, 12,
3213. Neosarpagine: Liao, X.; Huang, S.; Zhou, H.; Parrish, D.; Cook,
J. M. Org. Lett. 2007, 9, 1469. Carbovir/Aristeromycin: Trost, B. M.; Li,
L.; Guile, S. D. J. Am. Chem. Soc. 1992, 114, 8745.
(5) Achmatowicz, O., Jr.; Buckowski, P.; Szechner, B.; Zierchowska,
A.; Zamojski, A. Tetrahedron 1971, 27, 1973. Sugawara, K.; Imanishi,
Y.; Hashiyama, T. Tetrahedron: Asymmetry 2000, 11, 4529.
(10) The isomerization of π-allyl-Pd complexes by Pd(0) has been
previously implicated in the loss of stereospecificity in Pd-AA reactions:
Takahashi, T.; Jinbo, Y.; Kitamura, K.; Tsuji, J. Tetrahedron Lett. 1984,
25, 5921. Granberg, K. L.; Backvall, J. E. J. Am. Chem. Soc. 1992, 114,
6858.
(6) Trost, B. M.; Verhoeven, T. R. J. Org. Chem. 1976, 41, 3215.
(7) Crystal data: monoclinic, space group P21/c (No. 14), (a)
˚
˚
˚
€
7.7627(3) A, (b) 11.0574(4) A, (c) 11.2765(4) A, (β) 103.614(2)°, (V)
940.73(6) A , (Z) 4.
3
˚
(8) For examples of strain energy in 5,6-ring systems, see: Velluz, L.;
ꢀ
(11) Tsarev, V. N.; Wolters, D.; Gais, H.-J. Chem.;Eur. J. 2010, 16,
2904.
(12) The relative stereochemistry of 9 was assigned using NOE
Valls, J.; Nomine, G. Angew. Chem., Int. Ed. 1965, 4, 181.
(9) DFT calculations (B3LYP/6-31G*) were performed with
Spartan ’08. See Supporting Information for computational details.
correlation and comparison to the 3JHH values of 4.
B
Org. Lett., Vol. XX, No. XX, XXXX